Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
2.440
-0.060 (-2.40%)
At close: Oct 7, 2025, 4:00 PM EDT
2.470
+0.030 (1.23%)
After-hours: Oct 7, 2025, 7:47 PM EDT
Beyond Air Market Cap
Beyond Air has a market cap or net worth of $12.75 million as of October 7, 2025. Its market cap has decreased by -28.36% in one year.
Market Cap
12.75M
Enterprise Value
17.98M
1-Year Change
-28.36%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since May 8, 2019, Beyond Air's market cap has decreased from $50.50M to $12.75M, a decrease of -74.75%. That is a compound annual growth rate of -19.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 13.10M | -49.42% |
| Dec 31, 2024 | 25.90M | -58.69% |
| Dec 29, 2023 | 62.70M | -67.70% |
| Dec 30, 2022 | 194.10M | -22.82% |
| Dec 31, 2021 | 251.50M | 175.16% |
| Dec 31, 2020 | 91.40M | 62.63% |
| Dec 31, 2019 | 56.20M | 11.29% |
| May 8, 2019 | 50.50M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |